Skip to main content
ILLUMINA, INC. logo

ILLUMINA, INC. — Investor Relations & Filings

Ticker · ILMN ISIN · US4523271090 LEI · SQ95QG8SR5Q56LSNF682 US Manufacturing
Open in API
Filings indexed 2,572 across all filing types
Latest filing 2023-01-10 Director's Dealing
Country US United States of America
Listing US ILMN

About ILLUMINA, INC.

https://www.illumina.com

Illumina, Inc. develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company is a provider of DNA sequencing and array-based technologies. Its portfolio includes next-generation sequencing (NGS) platforms, microarrays, library preparation kits, and bioinformatics software. These products and services are utilized by researchers and clinicians for applications in life science research, translational and consumer genomics, molecular diagnostics, oncology, and reproductive health. The company's solutions are designed to advance genomic discoveries and enable precision medicine by providing tools for DNA, RNA, and protein analysis.

Recent filings

Filing Released Lang Actions
PRIMARY DOCUMENT
Director's Dealing
2023-01-10 English
8-K
Capital/Financing Update Classification · 100% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content describes the entry into a new credit agreement, replacing a previous credit agreement, detailing the terms of a $750 million revolving credit facility. This is a clear update on the company's financing activities. There are no financial statements or comprehensive financial data presented, only a description of the credit facility and its terms. Therefore, this document is best classified as a Capital/Financing Update (CAP). The document length is 7072 characters, which is sufficient to provide substantive detail about the financing event, not just a brief announcement or reference to another report.
2023-01-04 English
8-K
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a Current Report used to announce unscheduled material events or corporate changes. The content describes the issuance and sale of $1 billion aggregate principal amount of notes (debt securities) by Illumina, Inc., including details about the underwriting agreement, terms of the notes, and related exhibits. This is a clear update on the company's financing activities, specifically a debt offering. The document is not a full financial report, earnings release, or management discussion, but rather a capital/financing update. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length and detail support a high confidence in this classification.
2022-12-13 English
PRIMARY DOCUMENT
Director's Dealing
2022-12-08 English
8-K
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated November 29, 2022, reporting an underwritten public offering of debt notes by Illumina, Inc. It details the pricing of $500 million notes due 2025 and $500 million notes due 2027, with expected closing on December 13, 2022. The content focuses on a financing event, specifically a debt offering, and does not contain financial statements or earnings data. The document length is 3061 characters, which is relatively short but contains substantive information about a capital raising event. Therefore, this filing is best classified as a Capital/Financing Update (CAP).
2022-12-01 English
424B2
Capital/Financing Update Classification · 95% confidence The document is a prospectus supplement filed pursuant to Rule 424(b)(2) related to a debt securities offering, specifically $1 billion aggregate principal amount of notes due in 2025 and 2027. It includes detailed terms of the notes, underwriting information, risk factors, and legal disclaimers. The document is not a financial report, earnings release, or management discussion. It is a formal disclosure related to capital raising through debt issuance. This fits the definition of a Capital/Financing Update (CAP) filing, which covers updates on company fundraising and financing activities. The document length is substantial (15,000 characters), and it contains the full prospectus supplement, not just an announcement or link to a report, so it is not an RPA or RNS. Therefore, the correct classification is CAP with high confidence.
2022-12-01 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.